Immediate Impact
1 from Science/Nature 67 standout
Citing Papers
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
2024 Standout
Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a)
2024 Standout
Works of Daniel M Hoefner being referenced
Race Is a Key Variable in Assigning Lipoprotein(a) Cutoff Values for Coronary Heart Disease Risk Assessment
2015
Lipoprotein-Associated Phospholipase A2
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniel M Hoefner | 659 | 499 | 96 | 300 | 21 | 1.0k | |
| Hyun Jae Lee | 728 | 566 | 129 | 243 | 29 | 1.2k | |
| Lance Sullenberger | 715 | 573 | 75 | 276 | 17 | 1.1k | |
| G. R. Thompson | 743 | 446 | 160 | 232 | 29 | 1.3k | |
| Hal Kennedy | 870 | 604 | 155 | 286 | 21 | 1.3k | |
| Wim A. van der Steeg | 765 | 764 | 91 | 294 | 13 | 1.2k | |
| David Colquhoun | 620 | 334 | 82 | 331 | 16 | 1.0k | |
| Gissette Reyes‐Soffer | 629 | 352 | 154 | 385 | 37 | 1.0k | |
| Emil M. deGoma | 661 | 422 | 204 | 356 | 40 | 1.4k | |
| M van Linde-Sibenius Trip | 693 | 462 | 114 | 393 | 8 | 1.2k | |
| Brian T. Steffen | 589 | 305 | 138 | 376 | 46 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...